Literature DB >> 21656309

Risk factors influencing postoperative outcomes of major hepatic resection of hepatocellular carcinoma for patients with underlying liver diseases.

Tian Yang1, Jin Zhang, Jun-Hua Lu, Guang-Shun Yang, Meng-Chao Wu, Wei-Feng Yu.   

Abstract

BACKGROUND: Major hepatic resection of more than three segments in patients with hepatocellular carcinoma (HCC) is a high-risk operation, especially in patients with co-existing underlying liver diseases. The present study evaluated risk factors for postoperative morbidity and mortality after major hepatic resection in HCC patients with underlying liver diseases.
METHODS: Perioperative data of 305 HCC patients with underlying liver diseases who underwent major hepatic resection were evaluated by univariate and multivariate analyses to identify risk factors for postoperative morbidity and mortality.
RESULTS: The overall morbidity rate was 37.0% (n = 113), caused by pleural effusion (n = 56), ascites (n = 43), subphrenic effusion/infection (n = 23), hepatic dysfunction (n = 22), bile leakage (n = 10), respiratory infection (n = 7), incision infection (n = 7), intra-abdominal hemorrhage (n = 5), and others. The hospital mortality rate was 2.6% (n = 8), primarily caused by liver failure (4/8). Multivariate logistic regression analysis showed that preoperative platelet count <100 × 10(9)/l (P = 0.006), and increased intraoperative blood loss (≥ 800 ml) (P = 0.008) were independent risk factors of postoperative morbidity, and that preoperative prothrombin time >14 s (P = 0.015) and preoperative platelet count <100 × 10(9)/l (P = 0.007) were independent risk factors for significant hospital mortality.
CONCLUSIONS: Careful preoperative selection of patients in terms of the Child-Pugh classification and decrease of intraoperative blood loss are important measures to reduce postoperative morbidity after major hepatic resection in HCC patients with underlying liver diseases. Moreover, we should be aware that preoperative platelet count is independently associated with postoperative morbidity and mortality for those patients following major hepatic resection.

Entities:  

Mesh:

Year:  2011        PMID: 21656309     DOI: 10.1007/s00268-011-1161-0

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  39 in total

1.  Repeat hepatectomy for recurrent hepatocellular carcinoma.

Authors:  Toshiyuki Itamoto; Hideki Nakahara; Hironobu Amano; Toshihiko Kohashi; Hideki Ohdan; Hirotaka Tashiro; Toshimasa Asahara
Journal:  Surgery       Date:  2007-05       Impact factor: 3.982

2.  Factors affecting survival and long-term outcome in the cirrhotic patient undergoing hepatic resection for hepatocellular carcinoma.

Authors:  A Chiappa; A P Zbar; R A Audisio; B E Leone; F Biella; C Staudacher
Journal:  Eur J Surg Oncol       Date:  2000-06       Impact factor: 4.424

3.  No-mortality liver resection for hepatocellular carcinoma in cirrhotic and noncirrhotic patients: is there a way? A prospective analysis of our approach.

Authors:  G Torzilli; M Makuuchi; K Inoue; T Takayama; Y Sakamoto; Y Sugawara; K Kubota; A Zucchi
Journal:  Arch Surg       Date:  1999-09

4.  Surgical resection of hepatocellular carcinoma in cirrhotic patients: prognostic value of preoperative portal pressure.

Authors:  J Bruix; A Castells; J Bosch; F Feu; J Fuster; J C Garcia-Pagan; J Visa; C Bru; J Rodés
Journal:  Gastroenterology       Date:  1996-10       Impact factor: 22.682

5.  Major hepatic resections in infancy and childhood.

Authors:  J M Howat
Journal:  Gut       Date:  1971-03       Impact factor: 23.059

6.  Hospital mortality of major hepatectomy for hepatocellular carcinoma associated with cirrhosis.

Authors:  S T Fan; E C Lai; C M Lo; I O Ng; J Wong
Journal:  Arch Surg       Date:  1995-02

7.  Bloodless liver resection using the monopolar floating ball plus ligasure diathermy: preliminary results of 16 liver resections.

Authors:  Yoshihiro Sakamoto; Junji Yamamoto; Norihiro Kokudo; Makoto Seki; Tomoo Kosuge; Toshiharu Yamaguchi; Tetsuichiro Muto; Masatoshi Makuuchi
Journal:  World J Surg       Date:  2004-01-08       Impact factor: 3.352

8.  Platelets Strongly Induce Hepatocyte Proliferation with IGF-1 and HGF In Vitro.

Authors:  Ryota Matsuo; Nobuhiro Ohkohchi; Soichiro Murata; Osamu Ikeda; Yoritaka Nakano; Motonobu Watanabe; Katsuji Hisakura; Andriy Myronovych; Tomomi Kubota; Hisashi Narimatsu; Michitaka Ozaki
Journal:  J Surg Res       Date:  2007-08-03       Impact factor: 2.192

9.  Risk factors and management of ascites after liver resection to treat hepatocellular carcinoma.

Authors:  Takeaki Ishizawa; Kiyoshi Hasegawa; Norihiro Kokudo; Keiji Sano; Hiroshi Imamura; Yoshifumi Beck; Yasuhiko Sugawara; Masatoshi Makuuchi
Journal:  Arch Surg       Date:  2009-01

10.  Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: Model of End-Stage Liver Disease (MELD) score predicts perioperative mortality.

Authors:  Swee H Teh; John Christein; John Donohue; Florencia Que; Michael Kendrick; Michael Farnell; Stephen Cha; Patrick Kamath; Raymond Kim; David M Nagorney
Journal:  J Gastrointest Surg       Date:  2005-12       Impact factor: 3.267

View more
  71 in total

Review 1.  Surgical management of hepatocellular carcinoma.

Authors:  Tony Cy Pang; Vincent Wt Lam
Journal:  World J Hepatol       Date:  2015-02-27

Review 2.  Management of post-hepatectomy complications.

Authors:  Shan Jin; Quan Fu; Gerile Wuyun; Tu Wuyun
Journal:  World J Gastroenterol       Date:  2013-11-28       Impact factor: 5.742

3.  Interaction of key pathways in sorafenib-treated hepatocellular carcinoma based on a PCR-array.

Authors:  Yan Liu; Ping Wang; Shijie Li; Linan Yin; Haiyang Shen; Ruibao Liu
Journal:  Int J Clin Exp Pathol       Date:  2015-03-01

4.  Outcomes of simple saline-coupled bipolar electrocautery for hepatic resection.

Authors:  Jian-Yang Guo; De-Wei Li; Rui Liao; Ping Huang; Xian-Bing Kong; Ji-Ming Wang; Hong-Lin Wang; Shi-Qiao Luo; Xiong Yan; Cheng-You Du
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

5.  The influence of PEEP and positioning on central venous pressure and venous hepatic hemodynamics in patients undergoing liver resection.

Authors:  Asi Ukere; Sebastian Meisner; Gillis Greiwe; Benjamin Opitz; Daniel Benten; Björn Nashan; Lutz Fischer; Constantin J C Trepte; Daniel A Reuter; Sebastian A Haas; Christoph R Behem
Journal:  J Clin Monit Comput       Date:  2016-12-23       Impact factor: 2.502

6.  Nomogram for individualised prediction of liver failure risk after hepatectomy in patients with resectable hepatocellular carcinoma: the evidence from ultrasound data.

Authors:  Hao Hu; Hong Han; Xi Kun Han; Wen Ping Wang; Hong Ding
Journal:  Eur Radiol       Date:  2017-08-04       Impact factor: 5.315

7.  Impact of intraoperative blood loss on the short-term outcomes of laparoscopic liver resection.

Authors:  Rahul Gupta; David Fuks; Christophe Bourdeaux; Pejman Radkani; Takeo Nomi; Christian Lamer; Brice Gayet
Journal:  Surg Endosc       Date:  2017-03-31       Impact factor: 4.584

Review 8.  [Central venous pressure in liver surgery : A primary therapeutic goal or a hemodynamic tessera?]

Authors:  C R Behem; M F Gräßler; C J C Trepte
Journal:  Anaesthesist       Date:  2018-10       Impact factor: 1.041

9.  A multicentre, randomized clinical trial comparing the Veriset™ haemostatic patch with fibrin sealant for the management of bleeding during hepatic surgery.

Authors:  Robert Öllinger; Andre L Mihaljevic; Christoph Schuhmacher; Hüseyin Bektas; Florian Vondran; Moritz Kleine; Mauricio Sainz-Barriga; Sascha Weiss; Phillip Knebel; Johann Pratschke; Roberto I Troisi
Journal:  HPB (Oxford)       Date:  2012-12-27       Impact factor: 3.647

10.  Assessment of ISGLS definition of posthepatectomy liver failure and its effect on outcome in patients with hepatocellular carcinoma.

Authors:  Kenji Fukushima; Takumi Fukumoto; Kaori Kuramitsu; Masahiro Kido; Atsushi Takebe; Motofumi Tanaka; Tomoo Itoh; Yonson Ku
Journal:  J Gastrointest Surg       Date:  2013-12-03       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.